392 related articles for article (PubMed ID: 20522596)
1. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption.
Ussher JR; Koves TR; Cadete VJ; Zhang L; Jaswal JS; Swyrd SJ; Lopaschuk DG; Proctor SD; Keung W; Muoio DM; Lopaschuk GD
Diabetes; 2010 Oct; 59(10):2453-64. PubMed ID: 20522596
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of serine palmitoyl transferase I reduces cardiac ceramide levels and increases glycolysis rates following diet-induced insulin resistance.
Ussher JR; Folmes CD; Keung W; Fillmore N; Jaswal JS; Cadete VJ; Beker DL; Lam VH; Zhang L; Lopaschuk GD
PLoS One; 2012; 7(5):e37703. PubMed ID: 22629445
[TBL] [Abstract][Full Text] [Related]
3. Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides.
Cinar R; Godlewski G; Liu J; Tam J; Jourdan T; Mukhopadhyay B; Harvey-White J; Kunos G
Hepatology; 2014 Jan; 59(1):143-53. PubMed ID: 23832510
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of ceramide in slow-twitch muscle contributes to the development of insulin resistance in the obese JCR:LA-cp rat.
Fillmore N; Keung W; Kelly SE; Proctor SD; Lopaschuk GD; Ussher JR
Exp Physiol; 2015 Jun; 100(6):730-41. PubMed ID: 25786668
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of central de novo ceramide synthesis restores insulin signaling in hypothalamus and enhances β-cell function of obese Zucker rats.
Campana M; Bellini L; Rouch C; Rachdi L; Coant N; Butin N; Bandet CL; Philippe E; Meneyrol K; Kassis N; Dairou J; Hajduch E; Colsch B; Magnan C; Le Stunff H
Mol Metab; 2018 Feb; 8():23-36. PubMed ID: 29233519
[TBL] [Abstract][Full Text] [Related]
6. Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors.
Frangioudakis G; Garrard J; Raddatz K; Nadler JL; Mitchell TW; Schmitz-Peiffer C
Endocrinology; 2010 Sep; 151(9):4187-96. PubMed ID: 20660065
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
[TBL] [Abstract][Full Text] [Related]
8. The effect of high-fat diet and inhibition of ceramide production on insulin action in liver.
Zabielski P; Daniluk J; Hady HR; Markowski AR; Imierska M; Górski J; Blachnio-Zabielska AU
J Cell Physiol; 2019 Feb; 234(2):1851-1861. PubMed ID: 30067865
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle ceramides do not contribute to physical-inactivity-induced insulin resistance.
Appriou Z; Nay K; Pierre N; Saligaut D; Lefeuvre-Orfila L; Martin B; Cavey T; Ropert M; Loréal O; Rannou-Bekono F; Derbré F
Appl Physiol Nutr Metab; 2019 Nov; 44(11):1180-1188. PubMed ID: 30889368
[TBL] [Abstract][Full Text] [Related]
10. Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex.
Zhang QJ; Holland WL; Wilson L; Tanner JM; Kearns D; Cahoon JM; Pettey D; Losee J; Duncan B; Gale D; Kowalski CA; Deeter N; Nichols A; Deesing M; Arrant C; Ruan T; Boehme C; McCamey DR; Rou J; Ambal K; Narra KK; Summers SA; Abel ED; Symons JD
Diabetes; 2012 Jul; 61(7):1848-59. PubMed ID: 22586587
[TBL] [Abstract][Full Text] [Related]
11. Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome.
Yang G; Badeanlou L; Bielawski J; Roberts AJ; Hannun YA; Samad F
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E211-24. PubMed ID: 19435851
[TBL] [Abstract][Full Text] [Related]
12. Modulating serine palmitoyl transferase (SPT) expression and activity unveils a crucial role in lipid-induced insulin resistance in rat skeletal muscle cells.
Watson ML; Coghlan M; Hundal HS
Biochem J; 2009 Feb; 417(3):791-801. PubMed ID: 18922131
[TBL] [Abstract][Full Text] [Related]
13. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites.
Lee JS; Pinnamaneni SK; Eo SJ; Cho IH; Pyo JH; Kim CK; Sinclair AJ; Febbraio MA; Watt MJ
J Appl Physiol (1985); 2006 May; 100(5):1467-74. PubMed ID: 16357064
[TBL] [Abstract][Full Text] [Related]
14. Myriocin treatment affects lipid metabolism in skeletal muscles of rats with streptozotocin-induced type 1 diabetes.
Kurek K; Garbowska M; Ziembicka DM; Łukaszuk B; Rogowski J; Chabowski A; Górski J; Żendzian-Piotrowska M
Adv Med Sci; 2017 Mar; 62(1):65-73. PubMed ID: 28189121
[TBL] [Abstract][Full Text] [Related]
15. Involvement of de novo ceramide synthesis in pro-inflammatory adipokine secretion and adipocyte-macrophage interaction.
Hamada Y; Nagasaki H; Fujiya A; Seino Y; Shang QL; Suzuki T; Hashimoto H; Oiso Y
J Nutr Biochem; 2014 Dec; 25(12):1309-16. PubMed ID: 25283329
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane Prevents Hepatic Insulin Resistance by Blocking Serine Palmitoyltransferase 3-Mediated Ceramide Biosynthesis.
Teng W; Li Y; Du M; Lei X; Xie S; Ren F
Nutrients; 2019 May; 11(5):. PubMed ID: 31137828
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance.
Kurek K; Mikłosz A; Łukaszuk B; Chabowski A; Górski J; Żendzian-Piotrowska M
J Diabetes Res; 2015; 2015():154762. PubMed ID: 26380311
[TBL] [Abstract][Full Text] [Related]
18. The sphingosine-1-phosphate analog FTY720 reduces muscle ceramide content and improves glucose tolerance in high fat-fed male mice.
Bruce CR; Risis S; Babb JR; Yang C; Lee-Young RS; Henstridge DC; Febbraio MA
Endocrinology; 2013 Jan; 154(1):65-76. PubMed ID: 23183172
[TBL] [Abstract][Full Text] [Related]
19. Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats.
Babenko NA; Kharchenko VS
Biochemistry (Mosc); 2015 Jan; 80(1):104-12. PubMed ID: 25754045
[TBL] [Abstract][Full Text] [Related]
20. High-Mobility Group Box 1 Disrupts Metabolic Function with Cigarette Smoke Exposure in a Ceramide-Dependent Manner.
Taylor OJ; Thatcher MO; Carr ST; Gibbs JL; Trumbull AM; Harrison ME; Winden DR; Pearson MJ; Tippetts TS; Holland WL; Reynolds PR; Bikman BT
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
